VASCULAR ACCESS CATHETER MAINTENANCE
Promote patient safety and consistent practice

Reduce CLABSI rates with a customized dressing change system and easy-to-use line access products.

Request product sample

Maintain venous catheters with consistent aseptic technique

After insertion, each line access and dressing change could open the door for microbes to enter a patient’s body. In fact, most CLABSIs happen more than five days after a catheter is put in.1,2,3 We’ve created a system of products for catheter maintenance that helps protect patients by supporting evidence-based best practices for CLABSI prevention.

  • Our dressing change system gives clinicians everything they need to use consistent aseptic technique when replacing a dressing.
  • Innovative products help frontline staff prevent contamination at the line access site.
Grouping of 3 vascular access maintenance products.

Protect access sites with a customized dressing change system

Up to 70% of CLABSI infections can be avoided by following consistent evidence-based practices for prevention.2 Developed by nurses for nurses, our dressing change system intuitively guides clinicians left-to-right through sterile dressing changes. Completely customizable with the preferred products for your facility’s protocols, the system creates a sterile work area and organizes all components to prevent contamination at every step.

Request product sample

Click the icons to explore

Secure and disinfect insertion sites with easy-to-use products

We make it easier for clinicians to manage the insertion site with products designed to protect patients against infection. The Aegis CHG-impregnated foam disc helps inhibit bacteria on the surface of the dressing. A one-step dressing and securement system, SorbaView Shield protects the insertion site from pathogens and prevents catheter movement. The result: continued emphasis on patient safety after line access.

SorbaView Shield
SorbaView uses SHIELD securement technology that withstands multi-directional tugging forces. A clear film barrier protects the insertion site from contamination and allows thorough line assessment.

Request product sample

Aegis Hydrophilic Foam Disc
Uses chlorhexidine gluconate (CHG) to help inhibit disease causing microorganisms on the dressing’s surface. Effective for up to seven days after application, Aegis supports best practices for CLABSI prevention and is easy to apply.4,5,6,7

Request product sample

Standardize hub disinfection

Accessing the line happens multiple times a day, and each time there’s a potential for infection. The solution: Swabflush with SwabCap, a pre-filled saline flush syringe that includes a sterile disinfecting cap for protecting the needleless connector between line accesses. Clinicians can automatically disinfect the access hub after saline flushing with no additional supplies needed. Studies show that SwabFlush has increased hub disinfection compliance rates from less than 6% to more than 80%.8

Request product sample

Click the icons to explore

See how our products help promote
aseptic line maintenance

Simply complete this form and a Medline representative will contact you shortly.

Close-up of female caregiver's eye and top edge of a face mask, cropped in distinctive circular shape

Make CABSI prevention second nature

Explore our full Vascular Access Management Solution. From best practice guidance and education to the right system of products, we help you drive a culture of safety across your organization.

Learn more

References
1. The Joint Commission. Preventing Central Line-Associated Bloodstream Infections: A Global Perspective. Oak Brook, IL: Joint Commission Resources, May 2012. Available at: https://www.jointcommission.org/assets/1/18/CLABSI_Monograph.pdf Accessed October 21, 2016.
2. Association for Professionals in Infection Control and Epidemiology. Guide to Preventing Central Line-Associated Bloodstream
Infections. Washington, DC; APIC Implementation Guides, December 2015. Available at: http://www.apic.org/Professional-Practice/Implementation-guides#Preventing Accessed May 26, 2016.
3. Kamboj M, Blair R, Bell N, et al. Use of Disinfection Cap to Reduce Central Line-Associated Bloodstream Infection and Blood Culture Contamination Among Hematology-Oncology Patients. Infection Control & Hospital Epidemiology. 2015;36(12):1401-1408. Available at: http://www.idchula.org/wp-content/uploads/2016/01/Use-of-Disinfection-Cap-to-Reduce-CRBSI.pdf Accessed October 21, 2016.
4. Association for Professionals in Infection Control and Epidemiology. Guide to Preventing Central Line-Associated
Bloodstream Infections. Washington, DC; APIC Implementation Guides, December 2015. Available at: http://www.apic.org/Professional Practice/Implementation-guides#Preventing Accessed December 21, 2016.
5. The Joint Commission. Preventing Central Line-Associated Bloodstream Infections: A Global Perspective. Oak Brook, IL: Joint Commission Resources, May 2012. Available at: https://www.jointcommission.org/assets/1/18/CLABSI_Monograph.pdf Accessed December 21, 2016.
6. Guidelines for the Prevention of Intravascular Catheter-Related Infections, 2011. O’Grady NP, Alexander M, Burns LA, et al. Centers for Disease Control and Prevention website. Available at: http://www.cdc.gov/hicpac/BSI/BSI-guidelines-2011.html. Accessed November 18, 2016.
7. Marschall J, Mermel LA, Fakih M, Hadaway L, Kallen A, O’Grady NP, Pettis AM, Rupp ME, Sandora T, Maragakis LL, Yokoe DS. Strategies to
Prevent Central Line-Associated Bloodstream Infections in Acute Care Hospitals: 2014 Update. Infection Control and Hospital Epidemiology, Vol. 35, No. 7 (July 2014), pp. 753-771. Available at http://www.jstor.org/stable/10.1086/676533. Accessed November 18, 2016.
8. Seiler, L. Rachel, Meyer, Shante, Bayshore Medical Center Case study. Improving Infection Control Compliance Using Combined Cap/Flush Syringe Technology to Reduce Central Line Associated Infections